TAPPAHANNOCK, VA – Lung cancer is often called a “silent disease” because it frequently shows no symptoms in its earliest stages. By the time signs appear, the disease has often progressed, requiring more invasive and aggressive treatment. To help detect lung cancer earlier, when it is most treatable, VCU Health Tappahannock Hospital will offer a lung cancer screening event on Saturday, March 28, from 9:00 a.m. to 1:00 p.m., by appointment only.

Lung cancer remains the leading cause of cancer deaths in the United States and in the Northern Neck region. However, medical advancements in screening technology are changing the narrative for high-risk individuals.

The screening is designed for individuals at higher risk for lung cancer, particularly those who are current or former long-term, heavy smokers. Screening is generally recommended for adults ages 55 to 70 with a significant smoking history. To be eligible for Medicare-Medicaid covered lung cancer screening; patients must meet all the following requirements:

  • Age: 50 to 77 years old.
  • Symptoms: Asymptomatic (no signs or symptoms of lung cancer).
  • Smoking History: A “20 pack-year” or more history (e.g., 1 pack/day for 20 years, or 2 packs/day for 10 years).
  • Smoking Status: A current smoker or one who has quit within the last 15 years.
  • Order: A written order from a physician or qualified non-physician practitioner.

The screening uses low-dose computed tomography (LDCT), a quick, painless, and non-invasive scan that can detect lung cancer at much earlier stages—often before symptoms appear. The LDCT scan:

  • Uses no dyes (contrast)
  • Requires no injections
  • Involves nothing to swallow
  • Takes less than five minutes to complete from start to finish

Research shows that LDCT screening for eligible, high-risk individuals can significantly improve survival rates by identifying lung cancer early, when treatment options are less invasive and more effective.

Appointments are required for the March 28 screening event, and eligibility criteria apply. To learn more 804-827- 5864 (LUNG).

Why Screening is Vital

The primary goal of screening is to find lung cancer early, when it is most treatable and more likely to be curable. The impact on survival rates is significant:

  • Improved Survival: If lung cancer is caught before it spreads, the likelihood of surviving five years or more improves to 65%. Once the cancer reaches distant sites, that survival rate drops to just 6%.
  • Cure Rates: When detected in its earliest stage, lung cancer has an approximately 85% cure rate.
  • Reduced Mortality: Large-scale studies have proven that annual LDCT screening significantly reduces mortality for high-risk individuals.